PNC Financial Services Group’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Other funds holding PYXS
PNC Financial Services Group's PYXS Position: Q3 2026 in Review
PNC Financial Services Group held its Pyxis Oncology (PYXS) position steady in Q3 2026 at 6,500 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3989.
PNC Financial Services Group first reported a position in PYXS in Q1 2023 and has held it in 5 quarters since. The position peaked at $19.6K in Q2 2026. 101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.
- PNC Financial Services Group held 6,500 shares of Pyxis Oncology worth $15.1K as of Q3 2026.
- PNC Financial Services Group left its Pyxis Oncology share count unchanged in Q3 2026.
- Pyxis Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3989 holding.
- PNC Financial Services Group first reported a position in Pyxis Oncology in Q1 2023 and has held it in 5 quarters since.
- PNC Financial Services Group's Pyxis Oncology position peaked at $19.6K in Q2 2026.
- 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.